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Abstract
 
Ultraviolet (UV) radiation plays a critical role in the induction of nonmelanoma skin cancer.
UV radiation is also immune suppressive, and the immune suppression induced by UV irradia-
tion has been identified as a major risk factor for skin cancer induction. Previously, we showed
that UV exposure activates a cytokine cascade involving prostaglandin (PG)E
 
2
 
, interleukin
(IL)-4, and IL-10 that induces immune suppression. However, the earliest molecular events
that occur immediately after UV exposure, especially those upstream of PGE
 
2
 
, are not well de-
fined. UV-irradiated keratinocytes secrete the inflammatory phospholipid mediator, platelet-
activating factor (PAF). Because PAF upregulates the production of immunomodulatory com-
pounds, including PGE
 
2
 
, we tested the hypothesis that UV-induced PAF activates cytokine
production and initiates UV-induced immune suppression. Both UV and PAF activated cy-
clooxygenase (COX)-2 and IL-10 reporter gene construct transcription. PAF mimicked the
effects of UV in vivo and suppressed delayed-type hypersensitivity (DTH). Furthermore, im-
mune suppression was blocked when UV-irradiated mice were injected with PAF receptor
antagonists. In addition to the well-known role of PAF as a proinflammatory lipid mediator,
we propose that the PAF receptor senses cellular damage through the recognition of PAF and/
or PAF-like molecules, such as oxidized phosphatidylcholine, which activates cytokine tran-
scription and induces systemic immune suppression.
Key words: inﬂammation • lipid mediators • delayed-type hypersensitivity • tolerance/
suppression • immunomodulators
 
Introduction
 
Platelet-activating factor (PAF;
 
* 
 
1-
 
O
 
-alkyl-2-acetyl-
 
sn
 
-glyc-
ero-3-phosphocholine) is a phospholipid mediator with po-
tent biological effects. As the name implies, PAF activates a
wide variety of cells, including platelets, monocytes, mast
cells, and polymorphonuclear leukocytes. It also promotes
the migration of granulocytes to sites of inflammation and is
mitotic for fibroblasts and lymphocytes (for a review, see
reference 1). De novo synthesis of PAF occurs via a two
step pathway. Phospholipase-A
 
2
 
 enzymatically cleaves arachi-
donic acid from the 
 
sn-2
 
 position of cell membrane phos-
phatidylcholine. An acetyl residue is then transferred to the
free hydroxyl from acetyl-CoA to form biologically active
PAF (2). Cells that release PAF (endothelial cells, leuko-
cytes, and monocytes) do not contain preformed stores of
PAF, but rapidly synthesize PAF in response to stress. Cells
responsive to PAF express a single specific receptor, a seven
transmembrane spanning G-coupled protein. In addition to
PAF, this receptor recognizes structural analogs of PAF,
generated by oxidation of phosphatidylcholine. These frag-
mented phosphatidylcholine molecules (PAF-like lipids)
bind to and activate the PAF receptor. Binding of the PAF-
receptor stimulates a variety of downstream effects, includ-
ing activation of the mitogen-activated protein (MAP)
kinase pathway, activation of phospholipases, and the bio-
synthesis of a variety of cytokines and prostaglandins (for a
review by Ishii and Shimizu, see reference 3). Platelet-acti-
vating factor and PAF-receptor binding has been shown to
play a role in cellular communications in a variety of differ-
ent organ systems, including the vascular system, the central
nervous system, the endocrine system, and the gastrointesti-
nal tract (1); however, a role for PAF in systemic immuno-
suppression is unknown.
The major focus of research in our laboratory is to deter-
mine the mechanisms underlying the immune suppression
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induced by the environmental immunotoxin, UV radia-
tion. The primary cause of nonmelanoma skin cancer, the
most prevalent form of human neoplasia is the UV radia-
tion found in sunlight. The immune suppressive effects of
UV radiation contribute to skin cancer induction by de-
pressing cell-mediated immune reactions that normally
serve to destroy the developing highly antigenic skin tu-
mors. Epidemiological studies with immune suppressed re-
nal transplant patients (4), experiments with laboratory
mice (5), and immunologic studies with skin cancer pa-
tients (6), support the hypothesis that the immune suppres-
sion induced by UV exposure is a major risk factor for skin
cancer induction.
In addition, UV exposure suppresses the immune re-
sponses to infectious organisms. This has been shown using
both experimental animals (7) and human volunteers (8).
In fact, the immune suppression induced by sunlight expo-
sure is believed to play a major role in herpes viral recru-
descence (9). In many of the studies examining the effects
of UV radiation on the immune response to infectious
agents, significant and substantial immune suppression is
found after a single exposure to UV radiation. Further, the
doses of UV radiation given in the experimental studies
compare well to the amount of UV in sunlight that is re-
ceived during normal occupational and recreational activi-
ties (8, 10). Because UV-induced immune suppression
contributes to skin cancer induction, and in view of the
fact that a single exposure to sunlight can suppress the im-
mune response to microbial antigens, it is critically impor-
tant to study the mechanism(s) underlying UV-induced
immune suppression.
Considerable evidence exists supporting a role for UV-
induced biological response modifiers in activating systemic
immune suppression, including PGE
 
2
 
, cis-urocanic acid,
histamine, IL-10, IL-4, and TNF-
 
 
 
 (11). Although the in-
terplay between these various UV-induced cytokines is
complex and not completely understood, it does appear
that a cytokine cascade is activated that ultimately induces
immune suppression. Previous studies from our laboratory
suggest that an early step in this cytokine cascade is UV-
induced PGE
 
2
 
 production, which then causes downstream
effects, including the secretion of IL-4 and IL-10 into the
serum (12). The ultimate target of the these immunoregu-
latory cytokines is the dendritic cell, as one consequence of
total body UV-irradiation on dendritic cell function is to
suppress the secretion of IL-12p70 while at the same time
promoting IL-12p40 homodimer production (13). Sup-
pressed IL-12p70 secretion coupled with production of the
IL-12p40 homodimer, a natural antagonist of biologically
active IL-12, may explain why antigen-presenting cells iso-
lated from the lymphoid organs of UV-irradiated mice fail
to present antigen to Th1 clones (14).
Although our previous studies indicate an essential role
for UV-induced keratinocyte-derived PGE
 
2
 
 in systemic
immune suppression, the earliest molecular events that oc-
cur immediately after UV exposure are not well defined.
Some have suggested that UV exposure can directly acti-
vate PGE
 
2
 
 synthesis in keratinocytes (15), whereas others
have suggested that PGE
 
2
 
 secretion results only after a syn-
ergistic interaction between UV and endogenous media-
tors, such as histamine (16). This raises the possibility that
the molecular targets of UV radiation in keratinocytes are
upstream of cyclooxygenase (COX)-2 activation.
One potential candidate is PAF. Although PAF is not
expressed in normal skin, keratinocytes and corneal stro-
mal cells secrete PAF in response to UV exposure (17–19).
Of particular interest are the observations that kerati-
nocytes express PAF receptors on their surface (20) and
that PAF upregulates COX-2 gene expression and PGE
 
2
 
secretion by keratinocytes (21). Moreover, PAF receptor
antagonists block UV-induced apoptosis (17). These stud-
ies suggest that UV-induced PAF may be upstream of
PGE
 
2
 
 in the cascade of events that lead to UV-induced
immune suppression. The focus of the experiments pre-
sented here is to test the hypothesis that PAF plays a role in
systemic immune suppression.
 
Materials and Methods
 
Reagent and Cell Lines.
 
The metabolically stable analogue of
PAF, carbamyl-PAF (cPAF), and the PAF receptor antagonists
PCA-4248 (22), CV-3988 (23), and (
 
 
 
)trans-2,5-bis(3,4,5-tri-
methoxyphenyl)-1,3-dioxolane (hereafter referred to as diox-
olane [24] were purchased from Biomol). Egg yolk phosphatidyl-
choline was purchased from Sigma-Aldrich. Dr. Peter Isakson
(G.D. Searle & Co., St. Louis, MO) provided SC-236 the selec-
tive COX-2 inhibitor. Stock solutions of cPAF, PCA-4248, CV-
3988, dioxolane, and SC-236 were prepared at 5 mM concentra-
tions by dissolving each in a 50% DMSO/PBS buffer and diluted
further in PBS before cell culture or injection into mice. A thin
layer of phosphatidylcholine (5 mM in PBS) was spread into a
polystyrene dish and irradiated with 200 J/m
 
2
 
 UVB under an FS-
40 sunlamp. Irradiated solutions of phosphatidylcholine are re-
ferred to as UV-PC. The spontaneously transformed mouse kera-
tinocyte cell line PAM-212 was obtained from Dr. Stuart Yuspa
(National Cancer Institute, Bethesda, MD).
 
Mice.
 
Specific pathogen-free female C3H/HeNCr (MTV
 
 
 
)
mice were obtained from the National Cancer Institute Frederick
Cancer Research Facility Animal Production Area (Frederick,
MD). The animals were maintained in facilities approved by the
Association for Assessment and Accreditation of Laboratory Ani-
mal Care International, in accordance with current regulations of
the United States Department of Health and Human Services. All
animal procedures were reviewed and approved by the Institu-
tional Animal Care and Use Committee. Within each experi-
ment all mice were age matched. The mice were 8–10 wk old at
the start of each experiment.
 
Radiation Sources.
 
A bank of six FS-40 sunlamps (National
Biological) was used to irradiate mice. These lamps emit a con-
tinuous spectrum from 270 to 390 nm; with peak emission at 313
nm; 
 
 
 
65% of the irradiation is within the UVB range (280–320
nm) of the solar spectrum. The irradiance of the six bulbs aver-
aged 10 W/m
 
2
 
, as measured by an IL-1700 research radiometer
(International Light, Inc.). Keratinocyte cultures, or the phos-
phatidylcholine solution were suspended in PBS and placed un-
der a single FS-40 sunlamp. The output of this lamp was 
 
 
 
1.5
W/m
 
2
 
, at a tube to target distance of 23 cm.
 
Delayed-type Hypersensitivity.
 
The dorsal hair of the mice was
removed with electric clippers, and the mice were exposed to 10 
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kJ/m
 
2
 
 of UVB radiation. Control mice were shaved but not ex-
posed to UV. 5 d later the animals were immunized by injecting
10
 
7
 
 formalin-fixed 
 
Candida albicans
 
 into each flank (subcutaneous
injection, nonirradiated site). 9 d later, each hind footpad was
measured with an engineer’s micrometer (Swiss Precision Instru-
ments), the thickness recorded and the animals were challenged
by injecting 50 
 
 
 
l of 
 
Candida
 
 antigen (Antigen Supply House)
into each hind footpad. Footpad thickness was measured again
18–24 h later and the mean footpad swelling for each mouse (left
foot 
 
 
 
 right foot 
 
 
 
 2) swelling was recorded. The mean footpad
swelling 
 
 
 
 the standard error of the mean for each group (
 
n
 
 
 
 
 
 5)
was calculated. The specific footpad swelling was calculated by
subtracting the mean footpad swelling found in control mice that
were not immunized, but were challenged from the swelling seen
in mice that were both immunized and challenged. Statistical dif-
ferences between the controls and experimental groups were de-
termined by use of a two-tailed Student’s 
 
t
 
 test, with a probability
of 
 
 
 
0.05 considered significant (Prism Statistical Software;
GraphPad Inc.).
 
Dual Luciferase Assay.
 
A dual luciferase assay was used to de-
termine the effects of UV radiation, and/or cPAF on COX-2 or
IL-10 promoter activity. The COX-2 promoter luciferase con-
struct was generated from a PCR product comprising the 
 
 
 
1012
to 
 
 
 
12 nucleotides (relative to start of transcription) of the mouse
COX-2 5
 
 
 
 promoter region ligated into the pGL3-luc firefly lu-
ciferase vector purchased from Promega. Dr. Sandra Gollnick
(Roswell Park Cancer Institute, Buffalo, NY) provided the IL-10
promoter luciferase construct, which was originally prepared
from a genomic library and ligated into the pGL3-luc firefly lu-
ciferase vector (25). The fidelity of the constructs was determined
by sequencing. Dr. Menashe Bar-Eli (M.D. Anderson Cancer
Center, Houston, TX) provided us with the control 
 
 
 
-actin-
luciferase construct (mouse 
 
 
 
-actin promoter upstream of sea pansy
luciferase). Pam 212 cells were plated at a concentration of 5 
 
 
 
10
 
4
 
 cells/well in 24-well tissue culture plates and incubated over-
night at 37
 
 
 
C in 5% CO
 
2
 
. Plasmids containing the IL-10 pro-
moter or the COX-2 were mixed with the 
 
 
 
-actin sea pansy
luciferase control plasmid, the cationic liposomal transfection re-
agent Tfx-20, base DMEM culture medium, and then incubated
at 37
 
 
 
C for 15 min. 200 
 
 
 
l of the firefly/sea pansy mixture was
added to the Pam 212 cells in triplicate wells. The plates were
then incubated at 37
 
 
 
C. After 1 h each well was supplemented
with 800 
 
 
 
l of complete DMEM with 10% BCS and incubated at
37
 
 
 
C. After 24 h, the cell monolayers were washed, overlaid with
PBS, and exposed to UV radiation or cPAF. The plates were then
washed, resuspended in complete DMEM, and incubated for 36 h
at 37
 
 
 
C. At the end of the incubation, the cells were lysed, and
firefly luciferase activity was determined using a luminometer.
Immediately after the luciferase measurement the reaction was
quenched, the substrate mix for the sea pansy luciferase was
added, and a second reading was taken. The sea pansy luciferase
reading was used to normalize transfection efficiency. The lumi-
nescence from UV and/or cPAF-activated cultures was compared
with the luminescence obtained with control cultures (no UV
and tissue culture medium devoid of cPAF) and the stimulation
was expressed as fold increase.
 
Results
 
COX-2 and IL-10 Transcription Is Activated by UV Radia-
tion and cPAF and Inhibited by a PAF Receptor Antagonist.
 
To determine a potential role for PAF in activating cyto-
kine transcription, keratinocyte cultures transfected with
COX-2 or IL-10 reporter constructs were cultured with 10
nM cPAF or exposed to 200 J/m
 
2
 
 of UVB radiation. Met-
abolically stable cPAF was used because of its stability and
potency of action. At various times after the treatments, the
cells were lysed and assayed for luciferase activity. UV irra-
diation and cPAF stimulated both the COX-2 (Fig. 1 A)
and IL-10 promoter (Fig. 1 B) constructs. These data con-
firm that PAF and UV radiation can activate the COX-2
gene and demonstrate that PAF also activates IL-10 gene
transcription. Furthermore, the similar kinetics imply that a
shared responsive element is employed by PAF and UV ra-
diation to turn on cytokine gene transcription.
Next, we employed a PAF receptor antagonist to estab-
lish the order of events. If UV triggers multiple, parallel,
pathways for activating COX-2 and IL-10, then blocking
PAF receptor signaling would be insufficient to halt the in-
duction of both. Conversely, if these steps occur in a linear
sequence, than a PAF receptor antagonist should prevent
UV from activating COX-2 and IL-10 transcription. To
Figure 1. Upregulation of cy-
tokine gene transcription by PAF.
Murine keratinocytes were trans-
fected with a COX-2 reporter
construct (A) or an IL-10 reporter
construct (B) and exposed to 200
J/m2 of UV radiation ( ) or cul-
tured with 10 nM cPAF ( ). The
PAF receptor antagonist, PCA-
4248, was added to the medium
before UV radiation ( ) or cPAF
( ). At the times indicated, the
cells were lysed and the luciferase
activity determined. The data is
expressed as fold-induction by
comparing the response of UV- or
cPAF-treated cells to that of kera-
tinocytes transfected with the re-
porter gene constructs and treated
with tissue culture medium. Each
point represents the mean   SEM
of three separate determinations. 
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test this hypothesis, we used the PAF-receptor antagonist,
PCA-4248 (22). Prior to UV irradiation, the keratinocytes
were cultured with 100 
 
 
 
M PCA-4248. The cells were
then exposed to UV radiation, or treated with 10 nM
cPAF (Fig. 1). UV-irradiated keratinocytes preloaded with
PCA-4248 failed to upregulate the expression of COX-2
(Fig. 1 A), or IL-10 (Fig. 1 B). Inhibition of cPAF-induced
COX-2 and IL-10 transcription demonstrated that the
PAF-receptor antagonist was biologically active. These data
indicate that UV-induced activation of cytokine transcrip-
tion is mediated by PAF through the PAF receptor and
suggest that UV-induced activation of PAF is upstream of
PGE
 
2
 
 production.
 
PAF Suppresses Delayed-type Hypersensitivity In Vivo.
 
Next, we tested the hypothesis that PAF activates immune
suppression. As shown in Fig. 2, the intraperitoneal injec-
tion of cPAF induced significant immune suppression, in a
dose-dependent manner. The immune suppression ob-
served when the mice were injected with 500 pmol cPAF
was similar to that seen when mice were exposed to 10
kJ/m
 
2
 
 of UVB radiation. These data indicate that cPAF
mimics the effects of UV radiation and induces systemic
immune suppression.
 
The PAF Receptor Antagonist PCA-4248 Blocks UV-induced
Immune Suppression.
 
To further test the hypothesis that
PAF is involved in UV-induced immune suppression, a
PAF-receptor antagonist was used to block PAF signal-
ing. Mice were first injected with various doses of PCA-
4248 in PBS, and then irradiated with 10 kJ/m
 
2
 
 of UVB
radiation. As the dose of PCA-4248 increased, so did pro-
tection against UV-induced immune suppression (Fig. 3).
In fact, at the highest dose of PCA-4248 used, we found
that the response of UV-irradiated, receptor antagonist-
injected mice was indistinguishable from the positive control
(
 
P
 
 
 
 
 
 0.05). These data indicate that blocking PAF receptor
signaling blocks UV-induced immune suppression.
 
Structurally Diverse PAF Receptor Antagonists Block UV-
induced Immune Suppression.
 
Lipid peroxidation causes the
formation of other biologically active lipids, such as perox-
isome proliferator activated receptor gamma agonists (26),
that have been shown to mediate immunomodulatory ef-
fects (27). Our conclusion that immune suppression is me-
diated by PAF is based on inhibition studies using only one
PAF receptor antagonist, PCA-4248. To ensure that the
effects that we see are not unique to PCA-4248, and con-
firm the role of PAF receptor activation in the induction of
immune suppression, we used two other structurally unre-
lated PAF receptor antagonists, CV-3988 (23) and diox-
olane (24). Groups of mice were injected with 500 nmol of
PCA-4248, CV-3988, or dioxolane and then exposed to
UV radiation. All three of the PAF receptor antagonists
blocked UV-induced immune suppression (Fig. 4). When
equal amounts of PCA-4248 and Dioxolane were injected
into UV-irradiated mice, total immune restoration was
noted. There was no significant difference between the re-
sponse of the positive control and mice exposed to UV and
Figure 2. PAF suppresses the induction of DTH. Mice were injected
with cPAF (50 to 5,000 pmol) or exposed to UV radiation (10 kJ/m2) 5 d
before immunization with C. albicans. 9 d later, the mice were challenged
with  Candida antigen. DTH was measured 24 h after challenge. The
background response (negative control) was measured in mice that were
not immunized but were challenged. The positive control was measured
in mice that were immunized and challenged. Results are expressed as
means   SEM. An asterisk (*) indicates a statistically significant difference
(P   0.01) from the positive control (two-tailed Student’s t test, n   5).
A representative experiment is shown; this experiment was repeated three
times with similar results.
Figure 3. Injecting a PAF receptor antagonist blocks UV-induced im-
mune suppression. Mice were injected with 5 to 500 nmol PCA-4248, a
PAF receptor antagonist 1 h before UV-irradiation (10 kJ/m2). 5 d later,
the mice were immunized with C. albicans, and 9 d later, challenged with
Candida antigen. DTH was measured 24 h after challenge. The back-
ground response (negative control) was measured in mice that were not
immunized but were challenged. The positive control was measured in
mice that were immunized and challenged. Results are expressed as
means   SEM. An asterisk (*) indicates a statistically significant difference
(P   0.01) from the positive control (two-tailed Student’s t test, n  5). A
representative experiment is shown; this experiment was repeated three
times with similar results. 
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treated with PCA-4248 and/or dioxolane. In addition a
significant difference (
 
P
 
 
 
 
 
 0.01) was noted between the re-
sponse observed in UV-irradiated mice and those exposed
to UV and injected with PCA-4248 and Dioxolane. In
mice exposed to UV and injected with CV-3988 we noted
a major reversal in immune suppression, in that there was a
significant difference between the response found in mice
exposed to UV and mice exposed to UV and injected with
CV-3988 (
 
P
 
 
 
 
 
 0.001). These data indicate that pharmaco-
logical blockade of the PAF receptor by structurally unre-
lated PAF-receptor antagonists block UV-induced immune
suppression, thereby providing further support for the hy-
pothesis that PAF receptor signaling is required for UV-
induced immune suppression.
 
UV-irradiated Phosphatidylcholine Induces Immune Suppres-
sion.
 
Data in the literature indicate that oxidative stress
converts phosphatidylcholine into PAF-like receptor ago-
nists (2, 28). Because UV radiation is a known activator of
oxidative stress, we proposed that UV radiation oxidizes
membrane lipids to become PAF-like receptor agonists,
contributing to immune suppression. Egg yolk phosphati-
dylcholine was dissolved in PBS, at various concentrations,
and spread thinly in polystyrene dishes to allow for com-
plete exposure to UV and atmospheric oxygen. The solu-
tions were exposed to 200 J/m
 
2
 
 UVB radiation. Groups of
mice were then injected with the irradiated phosphatidyl-
choline (UV-PC). Control groups received normal unirra-
diated phosphatidylcholine. The mice were then immu-
nized with 
 
C. albicans
 
, and delayed-type hypersensitivity
(DTH) was measured. We observed that UV-PC, but not
normal unirradiated phosphatidylcholine induced immune
suppression, in a dose-dependent manner (Fig. 5). These
findings suggest that UV-irradiation of plasma membranes
can convert normal phosphatidylcholine into an endoge-
nous inflammatory agent that activates immune suppression.
 
A Selective COX-2 Inhibitor Prevents Immune Suppression
Caused by UV Radiation and PAF Receptor Agonists.
 
In an
attempt to reconcile the data presented above with earlier
findings where we demonstrated that PGE
 
2
 
 activated a cy-
tokine cascade that ultimately lead to immune suppression
(12), we used the selective COX-2 inhibitor SC-236 to in-
hibit prostaglandin synthesis in vivo. If PAF receptor sig-
naling is upstream of PGE
 
2
 
 production, then SC-236
should inhibit PAF-induced immune suppression. If PAF
receptor signaling acts via a parallel mechanism, then SC-
236 should not reverse immune suppression. Immune sup-
pression was induced by one of three methods: UV radia-
tion, injecting cPAF, or injecting UV-PC. Duplicate
groups of mice were injected with 0.2 
 
 
 
g SC-236 before
UV radiation, cPAF, or UV-PC administration. The dose
of SC-236 used here was based on previous studies in
which 0.2 
 
 
 
g SC-236 totally blocked the immune suppres-
sion caused by exposing mice to 10 kJ/m
 
2
 
 of UVB radia-
tion (12). The results from this experiment are shown in
Fig. 6. As demonstrated above, UV exposure, or injecting
UV-PC and/or cPAF induced significant immune suppres-
sion. No immune suppression was observed in mice treated
with SC-236. These results confirm that prostaglandin syn-
Figure 4. Structurally diverse PAF receptor antagonists block UV-
induced immune suppression. Mice were injected with 500 nmol PCA
4248, CV-3988 or dioxolane, and then exposed to 10 kJ/m2 UV radia-
tion. 5 d later, the mice were immunized with C. albicans, and 9 d later,
challenged with Candida antigen. DTH was measured 24 h after challenge.
The background response (negative control) was measured in mice that
were not immunized but were challenged. The positive control was mea-
sured in mice that were immunized and challenged. Results are expressed
as means   SEM. * indicates a statistically significant difference (P  
0.01) from the positive control (two-tailed Student’s t test, n   5). # in-
dicates a statistically significant difference (P   0.01) from the response
found in UV-irradiated mice. A representative experiment is shown; this
experiment was repeated three times with similar results.
Figure 5. UV-irradiated phosphatidylcholine induces immune suppres-
sion. Mice were injected with 500 pmol cPAF, 500 nmol normal phos-
phatidylcholine, (PC) or 5 to 500 nmol UV-PC, 5 d before immuniza-
tion with C. albicans. 9 d later, the mice were challenged with Candida
antigen. DTH was measured 24 h after challenge. The background re-
sponse (negative control) was measured in mice that were not immunized
but were challenged. The positive control was measured in mice that
were immunized and challenged. Results are expressed as means   SEM.
An asterisk (*) indicates a statistically significant difference (P   0.01)
from the positive control (two-tailed Student’s t test, n   5). A represen-
tative experiment is shown; this experiment was repeated three times
with similar results.176 PAF Activates Immune Suppressive Pathways
thesis is essential for UV-induced immune suppression and
indicate that the immune suppression induced by injecting
cPAF and UV-PC work via a prostaglandin-dependent
mechanism. Furthermore, they suggest that UV-induced
activation of inflammatory lipid mediators is upstream of
PGE2 synthesis in the cascade of events leading to systemic
immune suppression.
Discussion
Because the systemic immune suppression induced by
UV radiation is a well-known risk factor for skin cancer in-
duction, it is important to understand the mechanisms in-
volved. In addition, after a single exposure to an environ-
mentally relevant dose of UV radiation the immune
response to viral, fungal, and bacterial antigens is signifi-
cantly suppressed. Ultraviolet radiation-induced, kerati-
nocyte-derived cytokines and immune modulatory factors
play an important role in the activation of systemic im-
mune suppression. Previous findings indicated that PGE2
production was an early step in the cascade of events lead-
ing to immune suppression (12). In response to UV radia-
tion, keratinocytes also produce and secrete the proinflam-
matory phospholipid mediator, PAF (17–19). Because PAF
promotes cytokine synthesis and upregulates COX-2 bio-
synthesis, we tested that hypothesis that PAF is involved in
the systemic immune suppression induced by UV radia-
tion. Our findings support a role for PAF in the induction
of immune suppression. PAF activates the transcription of
COX-2 and IL-10, two important mediators of systemic
immune suppression. Injecting PAF into mice mimics the
effect of UV radiation in vivo by suppressing DTH, and in-
jecting the PAF receptor antagonist blocks UV-induced
immune suppression. These findings suggest that in addi-
tion to being sensors for cellular damage, proinflammatory
oxidized phospholipids (PAF and PAF-like molecules) also
activate immune suppressive mechanisms. To our knowl-
edge, this is the first report demonstrating a systemic im-
munosuppressive role for PAF.
As mentioned above, synthesis of bona fide PAF occurs
via the enzymatic removal of sn-2 side chains from phos-
phatidylcholine by phospholipase-A2, followed by acetyla-
tion of the free hydroxyl moiety (2). In addition, fatty acid
side chains of phosphatidylcholine can become oxidized at
points of unsaturation and undergo a radical scission leaving
a shortened acyl chain at the sn-2 position and a hydroper-
oxide-alkyl byproduct. These fragmented phosphatidyl-
choline molecules (PAF-like lipids) signal through the PAF
receptor, which amplifies and sustains the biological signal
by inducing further PAF synthesis, arachidonic acid release,
and PGE2 synthesis (21). Ultraviolet radiation can upregu-
late PAF production in vivo by affecting different points of
this pathway. For example, UV radiation induces reactive
oxygen species that have been shown to upregulate PAF
production (29). Moreover, UV exposure upregulates
phospholipase-A2 activity (30).
An important mechanism for generating PAF-like mole-
cules from phosphatidylcholine involves degradation by re-
active oxygen species. As UV radiation induces free radical
formation under physiological conditions, this suggests that
cell membranes are targeted by UV radiation to initiate the
immunosuppressive pathway. Data from the experiments
presented here, in which UV-irradiation of cell-free phos-
phatidylcholine converts it to an immunosuppressive com-
pound, is consistent with this idea. Moreover, data in the
literature indicating that UV-induced membrane effects ac-
tivate gene expression (31, 32) provide further support for
UV-induced lipid oxidation as an initial step in UV-induced
immune suppression. On the other hand, a series of ex-
periments published by Kripke and coworkers showed
that repairing UV-induced DNA damage completely
blocked immune suppression and restored immune func-
tion in UV-irradiated individuals (33–37), suggesting that
DNA is the chromophore. How does one reconcile these
apparently conflicting results? After genomic stress, a cell
must progress through a series of checkpoints that deter-
mine whether that cell lives or dies. Ultraviolet exposure
promotes arrest at the G2/M checkpoint to allow for DNA
repair (38). If DNA repair is successful, progression through
the cycle continues, if not, apoptosis and cell death results.
As recently shown by Fornace and colleagues, MAP kinase
activation plays a critical role in the initiation of G2/M de-
lay after UV irradiation (39). Ultraviolet-induced DNA
damage activates MAP kinase p38, which subsequently ini-
tiates a cascade of events that promotes G2/M cell cycle ar-
rest. MAP kinase activation is also involved in the activa-
Figure 6. Blocking COX-2 activity in vivo abrogates PAF receptor ag-
onist-induced immune suppression. Mice were exposed to UV radiation
(10 kJ/m2), or injected with cPAF (500 pmol) or UV-PC (500 nmol)
with (black bars) or without (white bars) the selective COX-2 inhibitor,
SC 236. 5 d later, the mice were immunized with C. albicans. 9 d later,
the mice were challenged with Candida antigen. DTH was measured 24 h
after challenge. The background response (negative control) was mea-
sured in mice that were not immunized but were challenged. The posi-
tive control was measured in mice that were immunized and challenged.
Results are expressed as means   SEM. An asterisk (*) indicates a statisti-
cally significant difference (P   0.01) from the positive control (two-
tailed Student’s t test, n   5). A representative experiment is shown; this
experiment was repeated three times with similar results.177 Walterscheid et al.
tion of phospholipase-A2, the first enzymatic step in PAF
synthesis (40). Moreover, a feedback amplification loop
may be involved because activated phospholipase-A2 has
been shown to stimulate the appearance and activity of p38
(41). We propose that a side effect of the process used by
cells to repair UV-induced DNA damage and maintain ge-
nomic integrity in vivo is the induction of immune sup-
pression. The MAP kinase pathway controls G2/M check
point delay and at the same time increases the enzymatic
activity of phospholipase-A2. This results in the biosynthesis
of PAF, and PGE2 thus driving systemic immune suppres-
sion. This may explain why in all of our previous experiments,
repairing DNA damage completely reversed UV-induced
immune suppression, regardless of the experimental system
employed to measure immune function. Experiments are
currently in progress to determine the molecular mecha-
nisms underlying UV-induced PAF production.
There are a number of other observations in the litera-
ture supporting the suggestion that the maintenance of ge-
nomic integrity and the induction of UV-induced immune
suppression are closely linked. First, reactive oxygen spe-
cies, which are well known for their ability to induce DNA
damage (42), induce PAF synthesis (29). Second, no induc-
tion of immune suppression was found in UV-irradiated
apoptosis-deficient Fas and/or Fas-ligand–deficient mice
(43, 44). Third, in the past we have been able to induce cy-
tokine production and systemic immune suppression by in-
ducing nonspecific DNA damage with HindIII-containing
liposomes (45). We propose that the immune suppression
induced by HindIII containing-liposomes works via a
DNA damage-induced, MAP kinase-dependent, PAF-
driven mechanism, and studies are in progress to directly
test this hypothesis.
In addition to DNA, the other major chromophore for
UV-induced immune suppression is urocanic acid. Natu-
rally occurring trans-urocanic acid, found in the uppermost
layers of the skin, is isomerized by UV radiation into the
cis-isomer, which is a potent immune immunosuppressive
agent (46). Although it is uncertain how UV-induced cis-
urocanic acid fits into the pathway described above, pre-
liminary results from our laboratory indicate that we can
reverse cis-urocanic acid-induced suppression with PAF-
receptor antagonists (unpublished data). Therefore, we sug-
gest that cis-urocanic acid may be working in concert with
UV-induced DNA damage to amplify PAF biosynthesis
and contribute to immune suppression. This may explain
why repairing UV-induced pyrimidine dimer formation in
vivo will completely reverse immune suppression regardless
of the immune parameter tested, (i.e., both DTH and con-
tact hypersensitivity), whereas neutralization of cis-uro-
canic acid activity in vivo preferentially reverses some, but
not all examples of UV-induced suppression (47, 48).
The immunoregulatory role of PAF may not be limited
to UV-induced immune suppression. We propose that
PAF release and PAF-receptor binding may play a role in
the immune suppression induced by other dermal immu-
notoxins that suppress via PGE2-dependent pathways. One
example is the induction of systemic immune suppression
after dermal exposure to jet fuel (49). Jet fuels are lipophilic
reagents that damage DNA (50) and suppress via the pro-
duction of immune regulatory biological response modifi-
ers, such as IL-10 and PGE2 (51). Studies are in progress to
determine whether PAF and PAF-like molecules are in-
volved in jet fuel–induced immune suppression.
In summary, our data support an immunosuppressive
role for PAF. We suggest that UV-induced keratinocyte-
derived PAF binds to PAF receptors on adjacent cells and
drives cytokine transcription. This initiates a cytokine cas-
cade that ultimately results in systemic immune suppression.
We thank Nasser Kazimi for his assistance with the experiments re-
ported here; Dr. Peter Isakson, G.D. Searle & Co. for the selective
COX-2 inhibitor; Dr. Stuart Yuspa, National Cancer Institute for
the PAM 212 cells, and Dr. Sandra Gollnick, Roswell Park Cancer
Institute for the IL-10 promoter constructs.
This work was supported by research grants from the National
Cancer Institute (R01CA 75575 and R01CA 088943; SEU), a pre-
doctoral training grant from the National Cancer Institute (T32-
CA-09598-10, JPW), and pre-doctoral awards from the American
Legion (J.P. Walterscheid), the Shell Foundation (D.X. Nghiem),
and the R.E. “Bob” Smith Educational Fund (D.X. Nghiem) at the
M.D. Anderson Cancer Center. The animal facilities at the M.D.
Anderson Cancer Center are supported in part by a core grant from
the National Cancer Institute (CA 16672).
Submitted: 21 August 2001
Revised: 14 November 2001
Accepted: 28 November 2001
References
1. Prescott, S.M., G.A. Zimmerman, D.M. Stafforini, and T.M.
McIntyre. 2000. Platelet-activating factor and related lipid
mediators. Annu. Rev. Biochem. 69:419–445.
2. McIntyre, T.M., G.A. Zimmerman, and S.M. Prescott. 1999.
Biologically active oxidized phospholipids. J. Biol. Chem.
274:25189–25192.
3. Ishii, S., and T. Shimizu. 2000. Platelet-activating factor
(PAF) receptor and genetically engineered PAF receptor mu-
tant mice. Prog. Lipid Res. 39:41–82.
4. Penn, I. 2000. Post-transplant malignancy: the role of immu-
nosuppression. Drug Saf. 23:101–113.
5. Fisher, M.S., and M.L. Kripke. 1982. Suppressor T lympho-
cytes control the development of primary skin cancers in
UV-irradiated mice. Science. 216:1133–1134.
6. Yoshikawa, T., V. Rae, W. Bruins-Slot, J.W. vand-den-Berg, 
J.R. Taylor, and J.W. Streilein. 1990. Susceptibility to effects
of UVB radiation on induction of contact hypersensitivity as
a risk factor for skin cancer in humans. J. Invest. Dermatol. 95:
530-536.
7. Jeevan, A., and M.L. Kripke. 1989. Effect of a single expo-
sure to Ultraviolet radiation on Mycobacterium bovis Bacillus
Calmette-Guerin infection in mice. J. Immunol. 143:2837–
2843.
8. Goettsch, W., J. Garssen, W. Slob, F.R. de Gruijl, and H.
Van Loveren. 1998. Risk assessment for the harmful effects of
UVB radiation on the immunological resistance to infectious
diseases. Environ. Health Perspect. 106:71–77.
9. Norval, M., J. Garssen, H. Van Loveren, and A.A. el-Ghorr.
1999. UV-induced changes in the immune response to mi-178 PAF Activates Immune Suppressive Pathways
crobial infections in human subjects and animal models. J.
Epidemiol. 9:S84–92.
10. Nghiem, D.X., N. Kazimi, G. Clydesdale, H.N. Anan-
thaswamy, M.L. Kripke, and S.E. Ullrich. 2001. Ultraviolet
A radiation suppresses an established immune response: Im-
plications for sunscreen design. J. Invest. Dermatol. 117:1193–
1199.
11. Ullrich, S.E. 2000. The effects of ultraviolet radiation on the
immune response. In Biochemical Modulation of Skin Reac-
tions: Transdermals, Topicals, Cosmetics. A.F. Kydonieus
and J.J. Wille, editors. CRC Press, Boca Raton, FL. 281–
300.
12. Shreedhar, V., T. Giese, V.W. Sung, and S.E. Ullrich. 1998.
A cytokine cascade including prostaglandin E2, interleukin-4,
and interleukin-10 is responsible for UV-induced systemic
immune suppression. J. Immunol. 160:3783–3789.
13. Schmitt, D.A., and S.E. Ullrich. 2000. Exposure to ultravio-
let radiation causes dendritic cells/macrophages to secrete im-
mune suppressive IL-12p40 homodimers. J. Immunol. 165:
3162–3167.
14. Ullrich, S.E. 1994. Mechanism involved in the systemic sup-
pression of antigen-presenting cell function by UV irradia-
tion: Keratinocyte-derived IL-10 modulates antigen-present-
ing cell function of splenic adherent cells. J. Immunol. 152:
3410–3416.
15. Buckman, S.Y., A. Gresham, P. Hale, G. Hruza, J. Anast, J.
Masferrer, and A.P. Pentland. 1998. COX-2 expression is in-
duced by UVB exposure in human skin: Implications for the
development of skin cancer. Carcinogenesis. 19:723–729.
16. Jaksic, A., J.J. Finlay-Jones, C.J. Watson, L.K. Spencer, I.
Santucci, and P.H. Hart. 1995. Cis-urocanic acid synergizes
with histamine for increased PGE2 production by human ke-
ratinocytes: Link to indomethacin-inhibitable UVB-induced
immunosuppression. Photochem. Photobiol. 61:303–309.
17. Barber, L.A., D.F. Spandau, S.C. Rathman, R.C. Murphy,
C.A. Johnson, S.W. Kelley, S.A. Hurwitz, and J.B. Travers.
1998. Expression of the platelet-activating factor receptor re-
sults in enhanced ultraviolet B radiation-induced apoptosis in
a human epidermal cell line. J. Biol. Chem. 273:18891–
18897.
18. Sheng, Y., and D.L. Birkle. 1995. Release of platelet activat-
ing factor (PAF) and eicosanoids in UVC-irradiated corneal
stromal cells. Curr. Eye Res. 14:341–347.
19. Calignano, A., G. Cirino, R. Meli, and P. Persico. 1988. Iso-
lation and identification of platelet-activating factor in UV-
irradiated guinea pig skin. J. Pharmacol. Methods. 19:89–91.
20. Travers, J.B., J.C. Huff, M. Rola-Pleszczynski, E.W. Gel-
fand, J.G. Morelli, and R.C. Murphy. 1995. Identification of
functional platelet-activating factor receptors on human kera-
tinocytes. J. Invest. Dermatol. 105:816–823.
21. Pei, Y., L.A. Barber, R.C. Murphy, C.A. Johnson, S.W.
Kelley, L.C. Dy, R.H. Fertel, T.M. Nguyen, D.A. Williams,
and J.B. Travers. 1998. Activation of the epidermal platelet-
activating factor receptor results in cytokine and cyclooxyge-
nase-2 biosynthesis. J. Immunol. 161:1954–1961.
22. Fernandez-Gallardo, S., M.P. Ortega, J.G. Priego, M.F. de
Casa-Juana, C. Sunkel, and M. Sanchez Crespo. 1990. Phar-
macological actions of PCA 4248, a new platelet-activating
factor receptor antagonist: in vivo studies. J. Pharmacol. Exp.
Ther. 255:34–39.
23. Terashita, Z., Y. Imura, and K. Nishikawa. 1985. Inhibition
by CV-3988 of the binding of [3H]-platelet activating factor
(PAF) to the platelet. Biochem. Pharmacol. 34:1491–1495.
24. Corey, E.J., C.P. Chen, and M.J. Parry. 1988. Dual binding
modes to the receptor for platelet activating factor (PAFF) of
anti-PAF trans-2,5-diarylfurans. Tetrahedron Letters. 29:2899–
2902.
25. Gollnick, S.O., B.Y. Lee, L. Vaughan, B. Owczarczak, and
B.W. Henderson. 2001. Activation of the IL-10 gene pro-
moter following photodynamic therapy of murine kerati-
nocytes. Photochem. Photobiol. 73:170–177.
26. Davies, S.S., A.V. Pontsler, G.K. Marathe, K.A. Harrison,
R.C. Murphy, J.C. Hinshaw, G.D. Prestwich, A.S. Hilaire,
S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre. 2001.
Oxidized alkyl phospholipids are specific, high affinity perox-
isome proliferator-activated receptor gamma ligands and ago-
nists. J. Biol. Chem. 276:16015–16023.
27. Zhang, X., J.M. Wang, W.H. Gong, N. Mukaida, and H.A.
Young. 2001. Differential regulation of chemokine gene ex-
pression by 15-deoxy-delta 12,14 prostaglandin J2. J. Immu-
nol. 166:7104–7111.
28. Marathe, G.K., S.S. Davies, K.A. Harrison, A.R. Silva, R.C.
Murphy, H. Castro-Faria-Neto, S.M. Prescott, G.A. Zim-
merman, and T.M. McIntyre. 1999. Inflammatory platelet-
activating factor-like phospholipids in oxidized low density
lipoproteins are fragmented alkyl phosphatidylcholines. J.
Biol. Chem. 274:28395–28404.
29. Lewis, M.S., R.E. Whatley, P. Cain, T.M. McIntyre, S.M.
Prescott, and G.A. Zimmerman. 1988. Hydrogen peroxide
stimulates the synthesis of platelet-activating factor by endo-
thelium and induces endothelial cell-dependent neutrophil
adhesion. J. Clin. Invest. 82:2045–2055.
30. Gresham, A., J. Masferrer, X. Chen, S. Leal-Khouri, and
A.L. Pentland. 1996. Increased synthesis of high molecular
weight cPLA2 mediates early UV-induced PGE2 in human
skin. Am. J. Physiol. 270:C1037–C1050.
31. Simon, M.M., Y. Aragane, A. Schwarz, T.A. Luger, and T.
Schwarz. 1994. UVB light induces a nuclear factor  B
(NF B) activity independently from chromosomal DNA
damage in cell-free cytosolic extracts. J. Invest. Dermatol. 102:
422–427.
32. Devary, Y., R.A. Gottlieb, T. Smeal, and M. Karin. 1992.
The mammalian ultraviolet response is triggered by activation
of Src tyrosine kinases. Cell. 71:1081–1091.
33. Applegate, L.A., R.D. Ley, J. Alcalay, and M.L. Kripke.
1989. Identification of the molecular target for the suppres-
sion of contact hypersensitivity by UV radiation. J. Exp. Med.
170:1117–1131.
34. Kripke, M.L., P.A. Cox, L.G. Alas, and D.B. Yarosh. 1992.
Pyrimidine dimers in DNA initiate systemic immunosup-
pression in UV-irradiated mice. Proc. Natl. Acad. Sci. USA.
89:7516–7520.
35. Vink, A.A., A.M. Moodycliffe, V. Shreedhar, S.E. Ullrich, L.
Roza, D.B. Yarosh, and M.L. Kripke. 1997. The inhibition
of antigen-presenting activity of dendritic cells resulting from
UV irradiation of murine skin is restored by in vitro photore-
pair of cyclobutane pyrimidine dimers. Proc. Natl. Acad. Sci.
USA. 94:5255–5260.
36. Vink, A.A., F.M. Strickland, C. Bucana, P.A. Cox, L. Roza,
D.B. Yarosh, and M.L. Kripke. 1996. Localization of DNA
damage and its role in altered antigen-presenting cell func-
tion in ultraviolet-irradiated mice. J. Exp. Med. 183:1491–
1500.
37. Nishigori, C., D.B. Yarosh, S.E. Ullrich, A.A. Vink, C.D.
Bucana, L. Roza, and M.L. Kripke. 1996. Evidence that
DNA damage triggers interleukin 10 cytokine production in179 Walterscheid et al.
UV-irradiated murine keratinocytes. Proc. Natl. Acad. Sci.
USA. 93:10354–10359.
38. Gabrielli, B.G., J.M. Clark, A.K. McCormack, and K.A.
Ellem. 1997. Ultraviolet light-induced G2 phase cell cycle
checkpoint blocks cdc25- dependent progression into mito-
sis. Oncogene. 15:749–758.
39. Bulavin, D.V., Y. Higashimoto, I.J. Popoff, W.A. Gaarde, V.
Basrur, O. Potapova, E. Appella, and A.J. Fornace, Jr. 2001.
Initiation of a G2/M checkpoint after ultraviolet radiation re-
quires p38 kinase. Nature. 411:102–107.
40. Lin, L.L., M. Wartmann, A.Y. Lin, J.L. Knopf, A. Seth, and R.J.  
Davis. 1993. cPLA2 is phosphorylated and activated by MAP
kinase. Cell. 72:269-278.
41. Hii, C.S., Z.H. Huang, A. Bilney, M. Costabile, A.W. Mur-
ray, D.A. Rathjen, C.J. Der, and A. Ferrante. 1998. Stimula-
tion of p38 phosphorylation and activity by arachidonic acid
in HeLa cells, HL60 promyelocytic leukemic cells, and hu-
man neutrophils. Evidence for cell type-specific activation of
mitogen-activated protein kinases. J. Biol. Chem. 273:19277–
19282.
42. Pourzand, C., and R.M. Tyrrell. 1999. Apoptosis, the role of
oxidative stress and the example of solar UV radiation. Photo-
chem. Photobiol. 70:380–390.
43. Schwarz, A., S. Grabbe, K. Grosse-Heitmeyer, B. Roters, H.
Riemann, T.A. Luger, G. Trinchieri, and T. Schwarz. 1998.
Ultraviolet light-induced immune tolerance is mediated via
the Fas/Fas-ligand system. J. Immunol. 160:4262–4270.
44. Hill, L.L., V.K. Shreedhar, M.L. Kripke, and L.B. Owen-
Schaub. 1999. A critical role for Fas ligand in the active sup-
pression of systemic immune responses by ultraviolet radia-
tion. J. Exp. Med. 189:1285–1293.
45. Nishigori, C., D. Yarosh, A. O’Connor, V.K. Shreedhar,
S.E. Ullrich, P. Cox, and M.L. Kripke. 1998. HindIII lipo-
somes suppress delayed-type hypersensitivity responses in
vivo and induce epidermal IL-10 in vitro. J. Immunol. 161:
2684–2691.
46. De Fabo, E.C., and F.P. Noonan. 1983. Mechanism of im-
mune suppression by ultraviolet irradiation in vivo. I. Evi-
dence for the existence of a unique photoreceptor in skin and
its role in photoimmunology. J. Exp. Med. 157:84–98.
47. El-Ghorr, A.A., and M. Norval. 1995. A monoclonal anti-
body to cis-urocanic acid prevents the UV-induced changes
in Langerhans cells and DTH responses in mice, although not
preventing dendritic cell accumulation in lymph nodes drain-
ing the site of irradiation and contact hypersensitivity re-
sponses. J. Invest. Dermatol. 105:264–268.
48. Moodycliffe, A.M., C.D. Bucana, M.L. Kripke, M. Norval,
and S.E. Ullrich. 1996. Differential effects of a monoclonal
antibody to cis-urocanic acid on the suppression of delayed
and contact hypersensitivity following ultraviolet irradiation.
J. Immunol. 157:2891–2899.
49. Ullrich, S.E. 1999. Dermal application of JP-8 jet fuel in-
duces immune suppression. Toxicol. Sci. 52:61–67.
50. Grant, G.M., S.M. Jackman, C.J. Kolanko, and D.A. Stenger.
2001. JP-8 jet fuel-induced DNA damage in H4IIE rat
hepatoma cells. Mutat. Res. 490:67–75.
51. Ullrich, S.E., and H.J. Lyons. 2000. Mechanisms involved in
the immunotoxicity induced by dermal application of JP-8
jet fuel. Toxicol. Sci. 58:290–298.